$1.52 Billion is the total value of First Light Asset Management, LLC's 83 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 12.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRTA | Sell | PROTHENA CORPORATION PLC | $103,247,000 | +4.2% | 1,449,494 | -24.8% | 6.80% | +14.4% |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $98,521,000 | -19.8% | 6,263,260 | +4.6% | 6.49% | -11.9% |
| MODN | Buy | MODEL N INC | $83,031,000 | +12.1% | 2,478,532 | +14.6% | 5.47% | +23.1% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $60,105,000 | -35.4% | 1,477,496 | -27.9% | 3.96% | -29.1% |
| XENT | Sell | INTERSECT ENT INC | $58,122,000 | +53.8% | 2,136,823 | -3.4% | 3.83% | +68.9% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $57,205,000 | +11.1% | 479,186 | -9.3% | 3.77% | +22.0% |
| CDNA | Buy | CAREDX INC | $57,063,000 | -30.4% | 900,470 | +0.5% | 3.76% | -23.6% |
| OMCL | Sell | OMNICELL INC | $52,550,000 | -9.0% | 354,042 | -7.1% | 3.46% | -0.0% |
| NEO | Sell | NEOGENOMICS INC | $50,940,000 | -1.8% | 1,055,960 | -8.1% | 3.36% | +7.8% |
| ATRC | Sell | ATRICURE INC | $45,012,000 | -26.6% | 647,192 | -16.3% | 2.97% | -19.4% |
| OPRX | Sell | OPTIMIZERX CORP | $43,407,000 | +5.5% | 507,384 | -23.7% | 2.86% | +15.8% |
| STRO | Buy | SUTRO BIOPHARMA INC | $41,396,000 | +7.4% | 2,191,439 | +5.7% | 2.73% | +17.9% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL INC | $39,788,000 | +82.0% | 441,159 | +92.4% | 2.62% | +99.9% |
| HCAT | Buy | HEALTH CATALYST INC | $39,756,000 | -9.3% | 794,960 | +0.7% | 2.62% | -0.4% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $38,479,000 | -8.6% | 646,162 | +4.7% | 2.54% | +0.4% |
| CUTR | Sell | CUTERA INC | $35,823,000 | -28.2% | 768,727 | -24.5% | 2.36% | -21.1% |
| AXGN | Buy | AXOGEN INC | $35,380,000 | -26.3% | 2,239,261 | +0.8% | 2.33% | -19.1% |
| INSM | Sell | INSMED INC | $33,799,000 | -14.3% | 1,227,283 | -11.4% | 2.23% | -5.9% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $33,720,000 | +7.7% | 275,644 | +0.3% | 2.22% | +18.3% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $33,074,000 | -7.6% | 633,481 | +20.3% | 2.18% | +1.4% |
| BCYC | New | BICYCLE THERAPEUTICS PLC | $30,474,000 | – | 732,731 | +100.0% | 2.01% | – |
| TPTX | Buy | TURNING POINT THERAPEUTICS | $30,085,000 | -2.6% | 452,878 | +14.4% | 1.98% | +7.0% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $26,215,000 | -33.3% | 2,985,712 | -14.0% | 1.73% | -26.8% |
| XBI | Buy | SPDR S&P BIOTECH ETF | $25,720,000 | +129.8% | 204,600 | +147.5% | 1.70% | +152.2% |
| TEVA | Sell | TEVA PHARMACEUTICAL IND | $25,548,000 | -13.2% | 2,623,031 | -11.8% | 1.68% | -4.7% |
| MEIP | Buy | MEI PHARMA INC | $23,839,000 | +19.6% | 8,637,475 | +23.5% | 1.57% | +31.4% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOGIES | $22,249,000 | +5.4% | 341,825 | +2.7% | 1.47% | +15.8% |
| ATEC | Buy | ALPHATEC HOLDINGS INC | $21,633,000 | -19.8% | 1,774,668 | +0.8% | 1.42% | -11.9% |
| ITMR | Buy | ITAMAR MEDICAL LTD | $20,035,000 | +45.1% | 662,969 | +13.1% | 1.32% | +59.2% |
| PFMT | New | PERFORMANT FINANCIAL CORPORATION | $17,574,000 | – | 4,437,930 | +100.0% | 1.16% | – |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $16,487,000 | -48.7% | 577,663 | -39.2% | 1.09% | -43.6% |
| CDXS | Sell | CODEXIS INC | $16,275,000 | +2.1% | 699,716 | -0.5% | 1.07% | +12.1% |
| KRMD | Sell | REPRO-MED SYSTEMS INC | $15,414,000 | -38.6% | 5,408,426 | -0.3% | 1.02% | -32.6% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $15,231,000 | +4.9% | 232,492 | +1.1% | 1.00% | +15.3% |
| SIBN | Buy | SI-BONE INC | $15,116,000 | -31.8% | 705,682 | +0.2% | 1.00% | -25.1% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $13,646,000 | – | 176,559 | +100.0% | 0.90% | – |
| New | MAXCYTE INC | $12,145,000 | – | 994,670 | +100.0% | 0.80% | – | |
| GMAB | Sell | GENMAB AS | $11,318,000 | -54.3% | 258,991 | -57.3% | 0.75% | -49.8% |
| QDEL | Buy | QUIDEL CORP | $10,305,000 | +11.1% | 73,010 | +0.8% | 0.68% | +21.9% |
| STIM | Sell | NEURONETICS INC | $9,570,000 | -59.2% | 1,458,818 | -0.3% | 0.63% | -55.2% |
| SIEN | Buy | SIENTRA INC | $9,041,000 | +249.1% | 1,577,762 | +384.9% | 0.60% | +284.5% |
| Buy | APTOSE BIOSCIENCES INC | $9,000,000 | -34.1% | 4,128,443 | +0.3% | 0.59% | -27.7% | |
| ANNX | Buy | ANNEXON BIOSCIENCES INC | $9,003,000 | +94.1% | 483,773 | +134.8% | 0.59% | +113.3% |
| AKUMIN INC | $8,829,000 | -21.3% | 3,559,911 | 0.0% | 0.58% | -13.5% | ||
| WW | New | WW INTERNATIONAL INC | $8,363,000 | – | 458,273 | +100.0% | 0.55% | – |
| NVTA | Buy | INVITAE CORPORATION | $7,289,000 | -15.4% | 256,367 | +0.4% | 0.48% | -7.2% |
| KROS | New | KEROS THERAPEUTICS INC | $6,852,000 | – | 173,210 | +100.0% | 0.45% | – |
| MRVI | Sell | MARAVAI LIFE SCIENCES | $5,826,000 | -30.9% | 118,703 | -41.3% | 0.38% | -24.1% |
| JYNT | Sell | THE JOINT CORP | $5,443,000 | -44.5% | 55,525 | -52.4% | 0.36% | -38.9% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $5,284,000 | -50.0% | 620,887 | -3.6% | 0.35% | -45.1% |
| MIRO | MIROMATRIX MEDICAL INC | $3,306,000 | -40.3% | 475,000 | 0.0% | 0.22% | -34.3% | |
| SLP | Sell | SIMULATIONS PLUS INC | $2,967,000 | -28.7% | 75,123 | -0.9% | 0.20% | -22.0% |
| LHCG | Sell | LHC GROUP INC | $2,394,000 | -22.5% | 15,259 | -1.1% | 0.16% | -14.6% |
| RLAY | Sell | RELAY THERAPEUTICS INC | $1,635,000 | -88.6% | 51,848 | -86.7% | 0.11% | -87.4% |
| NARI | New | INARI MEDICAL, INC. | $952,000 | – | 11,734 | +100.0% | 0.06% | – |
| HRC | HILL ROM HOLDINGS | $652,000 | +32.0% | 4,346 | 0.0% | 0.04% | +43.3% | |
| AVTR | AVANTOR INC | $597,000 | +15.3% | 14,596 | 0.0% | 0.04% | +25.8% | |
| WAT | WATERS CORPORATION | $549,000 | +3.4% | 1,536 | 0.0% | 0.04% | +12.5% | |
| ITGR | INTEGER HOLDINGS CORPORATION | $522,000 | -5.3% | 5,846 | 0.0% | 0.03% | +3.0% | |
| SYNH | SYNEOS HEALTH INC CLASS A | $502,000 | -2.1% | 5,736 | 0.0% | 0.03% | +6.5% | |
| GSK | GLAXOSMITHKLINE PLC | $480,000 | -4.2% | 12,574 | 0.0% | 0.03% | +6.7% | |
| NVST | ENVISTA HOLDINGS CORP | $493,000 | -3.3% | 11,793 | 0.0% | 0.03% | +3.2% | |
| CVS | CVS HEALTH CORPORATION | $468,000 | +1.5% | 5,519 | 0.0% | 0.03% | +10.7% | |
| NUVA | NUVASIVE INC | $470,000 | -11.7% | 7,850 | 0.0% | 0.03% | -3.1% | |
| GILD | GILEAD SCIENCES INC | $468,000 | +1.3% | 6,705 | 0.0% | 0.03% | +10.7% | |
| BDX | BECTON DICKINSON AND CO | $464,000 | +1.1% | 1,888 | 0.0% | 0.03% | +10.7% | |
| BAX | BAXTER INTERNATIONAL INC | $477,000 | 0.0% | 5,929 | 0.0% | 0.03% | +6.9% | |
| ANTM | ANTHEM INC COM | $464,000 | -2.3% | 1,244 | 0.0% | 0.03% | +10.7% | |
| ICUI | ICU MEDICAL INC | $476,000 | +13.3% | 2,039 | 0.0% | 0.03% | +24.0% | |
| PRGO | PERRIGO COMPANY | $465,000 | +3.3% | 9,823 | 0.0% | 0.03% | +14.8% | |
| UTHR | UNITED THERAPEUTICS CORP DEL | $455,000 | +2.9% | 2,466 | 0.0% | 0.03% | +11.1% | |
| TAK | TAKEDA PHARMACEUTICAL CO | $420,000 | -2.6% | 25,630 | 0.0% | 0.03% | +7.7% | |
| BMY | BRISTOL-MYERS SQUIBB CO | $429,000 | -11.5% | 7,256 | 0.0% | 0.03% | -3.4% | |
| HOLX | HOLOGIC INC | $431,000 | +10.5% | 5,845 | 0.0% | 0.03% | +21.7% | |
| ABBV | ABBVIE | $403,000 | -4.3% | 3,740 | 0.0% | 0.03% | +8.0% | |
| HUM | HUMANA INC | $416,000 | -12.1% | 1,068 | 0.0% | 0.03% | -3.6% | |
| CI | CIGNA CORPORATION | $389,000 | -15.6% | 1,943 | 0.0% | 0.03% | -7.1% | |
| PFE | PFIZER INC | $364,000 | +9.6% | 8,469 | 0.0% | 0.02% | +20.0% | |
| JNJ | JOHNSON & JOHNSON | $349,000 | -2.0% | 2,161 | 0.0% | 0.02% | +9.5% | |
| SNY | SANOFI-SYNTHELABO | $321,000 | -8.3% | 6,650 | 0.0% | 0.02% | 0.0% | |
| UHS | UNIVERSAL HEALTH SERVICES, INC CLASS B | $284,000 | -5.3% | 2,050 | 0.0% | 0.02% | +5.6% | |
| MCK | MCKESSON CORP | $268,000 | +4.3% | 1,346 | 0.0% | 0.02% | +20.0% | |
| EBS | EMERGENT BIOSOLUTIONS INC | $215,000 | -20.4% | 4,294 | 0.0% | 0.01% | -12.5% | |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -15,400 | -100.0% | -0.08% | – |
| GKOS | Exit | GLAUKOS CORPORATION | $0 | – | -409,144 | -100.0% | -2.08% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS INC | $0 | – | -465,572 | -100.0% | -2.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.